Cargando...
A survey of the way pharmacokinetics are reported in published phase I clinical trials, with an emphasis on oncology
OBJECTIVES: During the drug development process, phase I trials are the first occasion to study the pharmacokinetics (PK) of a drug. They are performed in healthy volunteers, or patients in oncology, and are designed to determine a safe and acceptable dose for the later phases of clinical trials. We...
Gardado en:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Adis Intrnational Ltd
2009
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2799636/ https://ncbi.nlm.nih.gov/pubmed/19650677 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2165/00003088-200948060-00004 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|